3 Recruiting Urothelial Carcinoma Bladder Phase 2 Clinical Trials
Active phase 2 studies for urothelial carcinoma bladder enrolling across the USA. Verify eligibility and contact site coordinators.
All Urothelial Carcinoma Bladder studiesPhase 2 Studies for Urothelial Carcinoma Bladder
π΅ Active, Not Recruiting Phase2
Intravesical Gemcitabine and Docetaxel for BCG naΓ―ve Non-muscle Invasive Bladder Cancer
π Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center β Baltimore, Maryland
View Study & Checklist β π΅ Active, Not Recruiting Phase2
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
π Houston Methodist Hospital β Houston, Texas
View Study & Checklist β π’ Recruiting Phase2
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
π University of Florida β Gainesville, Florida
View Study & Checklist β